DNA repair and nutritional risk models of triple-negative breast cancer

被引：1
作者：
Hu, Jennifer
Lee, Eunkyung
Allen, Glenn
机构：
来源：
CANCER RESEARCH | 2014年 / 74卷 / 23期
关键词：
D O I：
10.1158/1538-7445.CANSUSC14-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10
引用
收藏
页数：1
相关论文
共 50 条
[31]   Triple-negative breast cancer: an update [J].
Boolbol, Susan K. ;
Cate, Sarah P. .
BREAST CANCER MANAGEMENT, 2014, 3 (02) :127-129
[32]   Immunotherapy in Triple-Negative Breast Cancer [J].
Tiberi, Elisa ;
Parisi, Alessandro ;
Pistelli, Mirco ;
Savini, Agnese ;
Galassi, Federica ;
Reschini, Chiara ;
Quintavalle, Debora ;
Napoleoni, Riccardo ;
Ferrari, Carlo ;
Berardi, Rossana .
ONCOLOGY AND THERAPY, 2025,
[33]   Targeting triple-negative breast cancer [J].
Kirkpatrick, Peter .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) :21-21
[34]   Pathogenesis of Triple-Negative Breast Cancer [J].
Derakhshan, Fatemeh ;
Reis-Filho, Jorge S. .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2022, 17 :181-204
[35]   Imaging of triple-negative breast cancer [J].
Dogan, B. E. ;
Turnbull, L. W. .
ANNALS OF ONCOLOGY, 2012, 23 :23-29
[36]   Morphotypes of the triple-negative breast cancer [J].
Koleckova, M. ;
Kolar, Z. ;
Ehrmann, J. ;
Korinkova, G. ;
Trojanec, R. .
VIRCHOWS ARCHIV, 2017, 471 :S296-S296
[37]   Metastatic Triple-negative Breast Cancer [J].
Rakha, E. A. ;
Chan, S. .
CLINICAL ONCOLOGY, 2011, 23 (09) :587-600
[38]   Pembrolizumab for triple-negative breast cancer [J].
Stirrups, Robert .
LANCET ONCOLOGY, 2020, 21 (04) :E183-E183
[39]   Targeting triple-negative breast cancer [J].
Peter Kirkpatrick .
Nature Reviews Drug Discovery, 2009, 8 :21-21
[40]   Chemoimmunotherapy for Triple-Negative Breast Cancer [J].
Slomski, Anita .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (24) :2521-2521
12345